Linola (Urea)

Urea acts as a hygroscopic molecule that attracts water into the outer skin layer, increasing hydration. It also disrupts hydrogen bonds within keratin proteins, weakening the skin’s protective barrier and facilitating the shedding of excess keratin. This dual action softens thickened skin and promotes natural desquamation.

The amount of Linola to apply is determined by the prescribing healthcare professional based on the severity of the condition, the area of skin involved and patient age. Typically, a thin layer is spread over the affected area once or twice daily, but exact instructions should follow the prescriber’s order.

Safety data for Linola in pregnancy and lactation are limited. The product’s pregnancy category is unknown, so it should only be used if the potential benefit justifies any possible risk to the fetus. Breastfeeding mothers should consult their physician before using Linola.

To order Linola, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linola’s urea base offers both moisturizing and keratolytic effects, whereas agents such as salicylic acid primarily provide keratolysis with less hydration. Urea is generally better tolerated on sensitive skin and can be combined with moisturizers, while stronger acids may cause more irritation but act more rapidly on thick plaques.

Linola should be stored at ambient temperature, away from direct sunlight and moisture. Keep the container tightly closed when not in use. Do not freeze the product, and ensure it is kept out of reach of children.

Linola is applied topically to clean, dry skin. A thin layer is spread over the affected area and gently massaged until absorbed. Frequency of application—usually once or twice daily—depends on the prescriber’s recommendation and the severity of the skin condition.

Serious risks, though rare, include allergic contact dermatitis, severe skin ulceration or bullous reactions, and systemic toxicity if large amounts are absorbed. Patients should stop using the product and seek medical attention if they notice extensive swelling, blistering, or systemic symptoms such as nausea or headache.

Linola should not be used on broken, infected or inflamed skin, and individuals with a known hypersensitivity to urea or any excipients in the formulation should avoid it. Patients with severe renal impairment should consult a physician before use, as systemic absorption may be increased.